Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects

NCT02144714 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
189
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samsung Bioepis Co., Ltd.